PS2 Patient Definition & Meaning | Health Care Term | CSIMarket

PS2 Patient

Health Care Term

PS2 Patient refers to a type of portable pulse oximeter device that is primarily used in the healthcare industry to assess the oxygen saturation levels in a person*s blood. The device is designed to be used by clinicians, nurses, or medical professionals to monitor patients* oxygen levels in real-time, especially during emergencies or surgeries.

The PS2 Patient pulse oximeter device works by attaching a small clip that contains sensors to the patient*s finger, earlobe, or toe. The clip then emits infrared light into the skin, which is absorbed by the oxygenated and deoxygenated blood molecules in the skin. The device calculates the oxygen saturation levels by comparing the amount of light absorbed by the two types of blood molecules.

The PS2 Patient pulse oximeter is highly accurate, reliable, and easy to use, making it an essential tool in many healthcare facilities. It provides continuous monitoring of oxygen levels, allowing medical professionals to quickly detect and respond to any abnormal changes in the patient*s condition.

The device is also portable, making it easy for medical professionals to move around with it while still being able to measure the patient*s blood oxygen levels. This feature is especially useful in critical care units, emergency rooms, and ambulances, where quick decision-making and immediate intervention are necessary.

In summary, the PS2 Patient pulse oximeter device is a vital tool in the healthcare industry, used to assess oxygen levels in patients* blood quickly and accurately. It allows medical professionals to monitor a patient*s oxygen saturation levels in real-time and take the necessary interventions to maintain the patient*s health.


More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P